Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder.

@article{Hollander2006DivalproexSV,
  title={Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder.},
  author={Eric Hollander and Latha Soorya and Stacey Wasserman and Katherine Esposito and William F. Chaplin and Evdokia Anagnostou},
  journal={The international journal of neuropsychopharmacology},
  year={2006},
  volume={9 2},
  pages={209-13}
}
Autism is a neurodevelopmental disorder characterized by impairment in three core symptom domains: socialization, communication, and repetitive/stereotyped behaviours. Other associated symptom domains are also affected including impulsivity/aggression, self-injury, anxiety, and mood lability. Divalproex has been shown to have efficacy in treating epilepsy, bipolar disorder, mood lability, and impulsive aggression. The present study evaluated the use of divalproex in the treatment of repetitive… CONTINUE READING